Viking Therapeutics, Inc. (VKTX)

CIK 1607678 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Viking Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002856
Oct 29, 202610-Q0001193125-26-436432
Oct 28, 20268-K0001193125-26-436145
Sep 28, 20268-K0001193125-26-405580
Sep 25, 2026424B50001193125-26-401384
Sep 25, 2026424B50001193125-26-401385
Sep 24, 2026FWP0001213900-26-102798
Sep 24, 2026305B20001213900-26-102782
Sep 23, 2026424B50001193125-26-399628
Sep 23, 2026424B50001193125-26-399627
Sep 22, 20268-K0001193125-26-397219
Aug 7, 202630002144542-26-000003
Aug 7, 202640002144542-26-000004
Jul 30, 2026S-3ASR0001193125-26-324455
Jul 29, 202640001193125-26-324446
Jul 29, 202610-Q0001193125-26-324219
Jul 29, 20261440001950047-26-007394
Jul 29, 20268-K0001193125-26-323652
Jul 29, 20261440001950047-26-007376
Jul 29, 20261440001950047-26-007380
Jul 29, 202640001193125-26-324447
Jul 29, 202640001193125-26-324448
Jun 3, 202630001193125-26-256038
Jun 3, 202640001193125-26-256039
May 26, 20268-K0001193125-26-239535